These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury? Salewski RP; Eftekharpour E; Fehlings MG J Cell Physiol; 2010 Mar; 222(3):515-21. PubMed ID: 20020443 [TBL] [Abstract][Full Text] [Related]
10. [Epidermolysis bullosa: first genetic stem cell therapy is successful]. Jung H Kinderkrankenschwester; 2007 Jan; 26(1):23. PubMed ID: 17294789 [No Abstract] [Full Text] [Related]
11. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells. Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228 [TBL] [Abstract][Full Text] [Related]
12. The joint battle to tackle epidermolysis bullosa through gene therapy. De Rosa L; De Luca M Trends Mol Med; 2022 Jul; 28(7):533-535. PubMed ID: 35599142 [TBL] [Abstract][Full Text] [Related]
13. Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015. Uitto J; Bruckner-Tuderman L; Christiano AM; McGrath JA; Has C; South AP; Kopelan B; Robinson EC J Invest Dermatol; 2016 Feb; 136(2):352-358. PubMed ID: 26802230 [TBL] [Abstract][Full Text] [Related]
14. Cardiac regeneration: still a 21st century challenge in search for cardiac progenitors from stem cells and embryos. Neri T; Stefanovic S; Pucéat M J Cardiovasc Pharmacol; 2010 Jul; 56(1):16-21. PubMed ID: 20631550 [TBL] [Abstract][Full Text] [Related]